DAFTAR PUSTAKA. 1. Baziad A. Endometriosis. Endokrinologi Ginekologi. Media Aesculapius. Fakultas Kedokteran Universitas Indonesia 2008.

Transcription

1 DAFTAR PUSTAKA 1. Baziad A. Endometriosis. Endokrinologi Ginekologi. Media Aesculapius Fakultas Kedokteran Universitas Indonesia Astarto NW, Djuwanto T, Permadi W, Madjid TH, Bayuaji H, Ritonga MA. Apakah endometriosis mengganggu fungsi endometrium normal?. Kupas Tuntas Kelainan Haid. Fakultas Kedokteran Universitas Padjajaran Djuwantono T, Bayuaji H, Permadi W. Bagaimana kita yakin itu endometriosis?. Penanganan Kelainan Endokrinologi Reproduksi dan Fertilitas dalam praktek sehari-hari. Fakultas Kedokteran Universitas Padjajaran Sourial S, Tempest N, Hapangama DK. Theories on the pathogenesis of endometriosis. International Journal of Reproductive Medicine Bulun SE. Mechanisms of disease endometriosis. The New England Journal of Medicine 2009;360(3): Siregar HS. L-selectin P213S polymorphism and macrophage profils in endometriosis; an new insight into the pathofisiology of endometriosis. Lambert Academic Publishing Burney RO, Giudice LC. Pathogenesis and pathophysiology of endometriosis. Fertility and Sterility

2 8. Zeitoun K. Takayama K, Sasano H, Suzuki T, Moghrabi N, Andersson S, et al. Deficient 17β-hydroxysteroid dehydrogenase type 2 expression in endometriosis: failure to metabolize 17β-estradiol. Journal of Clinical Endocrinology and Metabolism 1998;83(12): Burton KA, Henderson TA, Hillier SG, Mason JI, Habib F, Brenner RM, et al. Local levonogestrel regulation of androgen receptor and 17βhydroxysteroid dehydrogenase type 2 expression in human endometrium. European Society of Human Reproduction and Embryology 2003;18(12): Husen B, Psonka N, Meisel MJ, Keil C, Rune GM. Differential expression of 17β-hydroxysteroid dehydrogenase type 2 and 4 in human endometrial epithelial cell lines. Journal of Molecular Endocrinology 2000;24: Miettinen MM, Mustonen MVJ, Poutanen MH, Isomaa VV, Vihko R. Human 17β-hydroxysteroid dehydrogenase type 1 and type 2 isoenzymes have opposite activities in cultured cells and characteristic cell and tissue specific expression. Biochem. J. 1996;314: Carneiro MM, Morsch DM, Camargos AF, Spritzer PM, Reis FM. Expression of 17β-hydroxysteroid dehydrogenase type 2 in pelvic endometriosis. Gynecological Endocrinology 2007;23(4):

3 13. Cristescu C, Veliscu A, Marinescu B, Patrascu A, Tranca ET, Pop OT. Endometriosis clinical approach based on histological findings. Romanian Journal of Morphology & Embryology 2013;54(1): Velasco I, Rueda J, Acien P. Aromatase expression in endometriotic tissues and cell cultures of patients with endometriosis 2006;12(6): Bulun SE, Cheng YH, Pavone ME, Xue Q, Attar E, Trukhacheva E, et al. estrogen receptor-β, estrogen receptor-α, and progesterone resistance in endometriosis. Semin Reprod Med 2010;28(1): Ilie R, Ilie I. The Implication of Angiogenesis in Endometriosis. Biotechnology Molecular Biology and Nanomedicine 2014;2(1): Leyland N, Casper R, Laberge P, Singh SS. Endometriosis: diagnosis and management. Journal of Obstetrics abd Gynaecology Canada 2010;32(7): Endometriosis A Guide for Patients. American Society for Reproductive Medicine Schorge JO, Schaffer JI, Halvorson LM, Hoffman B, Bradshaw KD, Cunningham FG. Endometriosis. Williams Gynecology Suresh PS, Venkatesh T, Rajan T, Tsutsumi R. Molecular pathology and therapy of endometrriosis. Andrology and Gynecology Current Research 2013;1:

4 21. Bulun SE, Zeitoun K, Takayama K, Noble L, Michael D, Simpson E, et al. Estrogen production in endometriosis and use of aromatase inhibitors to treat endometriosis. Endocrine-Related Cancer 1999;6: Guideline of the European Society of Human Reproduction and Embryology. Management of women with endometriosis. ESHRE Endometriosis Guideline Development Group Vigano P, Rabellotti E, Pagliardini L, Somigliana E, Candiani M, Vercellini P. progesterone resistance, aromatase, and inflammation: the important relationships between hormones and inflammation. Curr obstet Gynecol Rep 2012;1: Pullen N. progesterone resistance and targeting the progesterone receptors: a therapeutic approach to endometriosis 2012: Huhtinen K. Molecular prifiling of human endometrium and endometriosis. University of Turku Miettinen M. 17β hydroxysteroid dehydrogenase types 1 and 2. Oulu University Library Rantakari P. the role of hydroxysteroid (17-beta) dehydrogenases 2,7, and 12 in mouse development. University of Turku Dunselman GAJ, Vermeulen N, Becker C, Jorge CC, Hooghe TD, Bie BD, et al. ESHRE guideline: management of women with endometriosis. Human Reproduction 2014;29(3):

5 29. Fadhlaoui A, Joliniere JB, Feki A. Endometriosis and infertility how and when to treat. Frontiers in surgery 2014;1(24) Fernandez EO, Ossadey CF. Clinical management of endometriosis from mild to severe. Global Congress on Minimally Invasive Gynecology Bhaskaran SS, Nair HB. Progestins/antiprogestins: role in pathogenesis and treatment for endometriosis. Gynecol Obstet 2012;2(3): Descamps P, Andreeva E, Leng J, Salehpour S, Chapron C. The place of gonadotropin-releasing hormone agonists in the management of endometriosis. Journal of Endometriosis and Pelvic Pain Disorders 2014: Faienza MF, Cavallo L. 17β-hydroxysteroid dehydrogenase type 3 deficiency: diagnosis, phenotypic variability and molecular findings. Department of Biomedicine of Developmental Age, University of Bari, Italy Peltoketo H, Luu-Tse V, Simard J, Adamski J. 17β-hydroxysteroid dehydrogenase (HSD) / 17-ketosteroid reductase (KSR) family; nomenclature and main characteristics of the 17HSD/KSR enzymes. Journal of Molecular Endocrinology 1999;23: Labrie F, Tse VL, Lin SX, Simard J, Labrie C, Alfy ME. Intracrinology: role of the family of 17β-hydroxysteroid dehydrogenase in human 50

6 physiology and disease. Journal of Molecular Endocrinology 2000;25: Bulun SE, Cheng YH, Pavone ME, Yin P, Imir G, Utsunomiya H, et al. 17β-hydroxysteroid dehydrogenase type 2 deficiency and progesterone resistance in endometriosis. Semin. Reprod. Med. 2010;28: Cheng YH, Yin P, Xue Q, Yilmaz B, Dawson MI, Bulun SE. Retinoic acid (RA) regulates 17β-hydroxysteroid dehydrogenase type 2 expression in endometrium: interaction of RA receptors with specificity protein (SP) 1/SP3 for estradiol metabolism. J. Clin. Endocrinol. Metab. 2008;93(5): Matsuzaki S, Canis M, Pouly JL, Dechelotte PJ, Mage G. analysis of aromatase and 17β-hydroxysteroid dehydrogenase type 2 messenger ribonucleic acid expression in deep endometriosis and eutopic endometrium using laser capture microdissection. Fertility and Sterility 2006;85(2): Bulun SE, Zeitoun KM, Takayama K, Sasano H. Estrogen biosynthesis in endometriosis: molecular basis and clinical relevance. Journal of Molecular Endocrinology 2000;25: Dassen H, Punyadeera, Kamps R, Delvoux B, Langendonckt AV. Donnez J, et al. Estrogen metabolizing enzymes in endometrium and endometriosis. Human Reproduction 2007;22(12):

7 41. Casey ML, Macdonald PC, Andersson S. 17β-hydroxysteroid dehydrogenase type 2: chromosomal assignment and progestin regulation of gene expression in human endometrium. 42. Cheng YH. Imir A, Suzuki T, Fenkci V, Yilmaz B, Sasano H, et al. sp1 and sp3 mediate progesterone-dependent induction of the 17beta hydroxysteroid dehydrogenase type 2 gene in human endometrium. Biology of Reproduction 2006;75: Agarwal A. Role of oxidative stress in endometriosis. Reproductive Biomedicine Online 2006;13(1): Meiling H, Lingya PL, Baozhen W. A case control epidemiologic study of endometriosis. Chinese Medical Science Journal 1994;9: